Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy   |   
enzyme (lysozyme)

 
Enzymes
  Enzyme classes:
  EC 1: Oxidoreductases
  EC 2: Transferases
    EC 2.1
    EC 2.2
    EC 2.3
      EC 2.3.1
        EC 2.3.1.1
        EC 2.3.1.2
        EC 2.3.1.3
        EC 2.3.1.4
        EC 2.3.1.5
        EC 2.3.1.6
        EC 2.3.1.7
        EC 2.3.1.8
        EC 2.3.1.9
        EC 2.3.1.10
        EC 2.3.1.11
        EC 2.3.1.12
        EC 2.3.1.13
        EC 2.3.1.14
        EC 2.3.1.15
        EC 2.3.1.16
        EC 2.3.1.17
        EC 2.3.1.18
        EC 2.3.1.19
        EC 2.3.1.20
        EC 2.3.1.21
        EC 2.3.1.22
        EC 2.3.1.23
        EC 2.3.1.24
        EC 2.3.1.25
        EC 2.3.1.26
        EC 2.3.1.27
        EC 2.3.1.28
        EC 2.3.1.29
        EC 2.3.1.30
        EC 2.3.1.31
        EC 2.3.1.32
        EC 2.3.1.33
        EC 2.3.1.34
        EC 2.3.1.35
        EC 2.3.1.36
        EC 2.3.1.37
        EC 2.3.1.38
        EC 2.3.1.39
        EC 2.3.1.40
        EC 2.3.1.41
        EC 2.3.1.42
        EC 2.3.1.43
        EC 2.3.1.44
        EC 2.3.1.45
        EC 2.3.1.46
        EC 2.3.1.47
        EC 2.3.1.48
        EC 2.3.1.49
        EC 2.3.1.50
        EC 2.3.1.51
        EC 2.3.1.52
        EC 2.3.1.53
        EC 2.3.1.54
        EC 2.3.1.55
        EC 2.3.1.56
        EC 2.3.1.57
        EC 2.3.1.58
        EC 2.3.1.59
        EC 2.3.1.60
        EC 2.3.1.61
        EC 2.3.1.62
        EC 2.3.1.63
        EC 2.3.1.64
        EC 2.3.1.65
        EC 2.3.1.66
        EC 2.3.1.67
        EC 2.3.1.68
        EC 2.3.1.69
        EC 2.3.1.70
        EC 2.3.1.71
        EC 2.3.1.72
        EC 2.3.1.73
        EC 2.3.1.74
        EC 2.3.1.75
        EC 2.3.1.76
        EC 2.3.1.77
        EC 2.3.1.78
        EC 2.3.1.79
        EC 2.3.1.80
        EC 2.3.1.81
        EC 2.3.1.82
        EC 2.3.1.83
        EC 2.3.1.84
        EC 2.3.1.85
        EC 2.3.1.86
        EC 2.3.1.87
        EC 2.3.1.88
        EC 2.3.1.89
        EC 2.3.1.90
        EC 2.3.1.91
        EC 2.3.1.92
        EC 2.3.1.93
        EC 2.3.1.94
        EC 2.3.1.95
        EC 2.3.1.96
        EC 2.3.1.97
        EC 2.3.1.98
        EC 2.3.1.99
        EC 2.3.1.100
        EC 2.3.1.101
        EC 2.3.1.102
        EC 2.3.1.103
        EC 2.3.1.104
        EC 2.3.1.105
        EC 2.3.1.106
        EC 2.3.1.107
        EC 2.3.1.108
        EC 2.3.1.109
        EC 2.3.1.110
        EC 2.3.1.111
        EC 2.3.1.112
        EC 2.3.1.113
        EC 2.3.1.114
        EC 2.3.1.115
        EC 2.3.1.116
        EC 2.3.1.117
        EC 2.3.1.118
        EC 2.3.1.119
        EC 2.3.1.120
        EC 2.3.1.121
        EC 2.3.1.122
        EC 2.3.1.123
        EC 2.3.1.124
        EC 2.3.1.125
        EC 2.3.1.126
        EC 2.3.1.127
        EC 2.3.1.128
        EC 2.3.1.129
        EC 2.3.1.130
        EC 2.3.1.131
        EC 2.3.1.132
        EC 2.3.1.133
        EC 2.3.1.134
        EC 2.3.1.135
        EC 2.3.1.136
        EC 2.3.1.137
        EC 2.3.1.138
        EC 2.3.1.139
        EC 2.3.1.140
        EC 2.3.1.141
        EC 2.3.1.142
        EC 2.3.1.143
        EC 2.3.1.144
        EC 2.3.1.145
        EC 2.3.1.146
        EC 2.3.1.147
        EC 2.3.1.148
        EC 2.3.1.149
        EC 2.3.1.150
        EC 2.3.1.151
        EC 2.3.1.152
        EC 2.3.1.153
        EC 2.3.1.154
        EC 2.3.1.155
        EC 2.3.1.156
        EC 2.3.1.157
        EC 2.3.1.158
        EC 2.3.1.159
        EC 2.3.1.160
        EC 2.3.1.161
        EC 2.3.1.162
        EC 2.3.1.163
        EC 2.3.1.164
        EC 2.3.1.165
        EC 2.3.1.166
        EC 2.3.1.167
        EC 2.3.1.168
        EC 2.3.1.169
        EC 2.3.1.170
        EC 2.3.1.171
        EC 2.3.1.172
        EC 2.3.1.173
        EC 2.3.1.174
        EC 2.3.1.175
        EC 2.3.1.176
        EC 2.3.1.177
        EC 2.3.1.178
        EC 2.3.1.179
        EC 2.3.1.180
        EC 2.3.1.181
        EC 2.3.1.182
        EC 2.3.1.183
        EC 2.3.1.184
        EC 2.3.1.185
        EC 2.3.1.186
      EC 2.3.2
      EC 2.3.3
    EC 2.4
    EC 2.5
    EC 2.6
    EC 2.7
    EC 2.8
    EC 2.9
  EC 3: Hydrolases
  EC 4: Lyases
  EC 5: Isomerases
  EC 6: Ligases
  General information:
  Catalytic mechanism
  Enzyme kinetics
  Inhibitors
  Enzymes in industry

EC 2.3.1.48 - acetyl- CoA:histone acetyltransferase



3D structures of EC 2.3.1.48 - histone acetyltransferase in Protein Data Bank

updated: 27 October 2021, 5:15

In total: 457 PDB structures of EC 2.3.1.48 - histone acetyltransferase:
  1. 1bob: Histone Acetyltransferase Hat1 from Saccharomyces Cerevisiae in Complex with Acetyl Coenzyme a
  2. 1f68: Nmr Solution Structure of The Bromodomain from Human Gcn5
  3. 3p1e: Crystal Structure of The Bromodomain of Human Crebbp in Complex with Dimethyl Sulfoxide (dmso)
  4. 3p1d: Crystal Structure of The Bromodomain of Human Crebbp in Complex with N-methyl-2-pyrrolidone (nmp)
  5. 3p1c: Crystal Structure of The Bromodomain of Human Crebbp in Complex with Acetylated Lysine
  6. 1n72: Structure and Ligand of a Histone Acetyltransferase Bromodomain
  7. 3kmr: Crystal Structure of Raralpha Ligand Binding Domain in Complex with an Agonist Ligand (am580) and a Coactivator Fragment
  8. 1p4q: Solution Structure of The Cited2 Transactivation Domain in Complex with The P300 Ch1 Domain
  9. 3ipu: X-ray Structure of Benzisoxazole Urea Synthetic Agonist Bound to The Lxr-alpha
  10. 3ips: X-ray Structure of Benzisoxazole Synthetic Agonist Bound to The Lxr- Alpha
  11. 3ipq: X-ray Structure of Gw3965 Synthetic Agonist Bound to The Lxr-alpha
  12. 3io2: Crystal Structure of The Taz2 Domain of P300
  13. 3i3j: Crystal Structure of The Bromodomain of Human Ep300
  14. 3hvl: Tethered Pxr-lbd/src-1p Complexed with Sr-12813
  15. 1qsm: Histone Acetyltransferase Hpa2 from Saccharomyces Cerevisiae in Complex with Acetyl Coenzyme a
  16. 1qso: Histone Acetyltransferase Hpa2 from Saccharomyces Cerevisiae
  17. 3h0a: Crystal Structure of Peroxisome Proliferator-activated Receptor Gamma (pparg) and Retinoic Acid Receptor Alpha (rxra) in Complex with 9-cis Retinoic Acid, Co-activator Peptide, and a Partial Agonist
  18. 3gg3: Crystal Structure of The Bromodomain of Human Pcaf
  19. 3g9e: Aleglitaar. a New. Potent, and Balanced Dual Ppara/g Agonist for The Treatment of Type II Diabetes
  20. 3g8i: Aleglitazar, a New, Potent, and Balanced Ppar Alpha/gamma Agonist for The Treatment of Type II Diabetes
  21. 3et3: Structure of Ppargamma with 3-[5-methoxy-1-(4-methoxy- Benzenesulfonyl)-1h-indol-3-yl]-propionic Acid
  22. 3et1: Structure of Pparalpha with 3-[5-methoxy-1-(4-methoxy- Benzenesulfonyl)-1h-indol-3-yl]-propionic Acid
  23. 1tot: Zz Domain of Cbp- a Novel Fold for a Protein Interaction Module
  24. 3dwy: Crystal Structure of The Bromodomain of Human Crebbp
  25. 1u2n: Structure Cbp Taz1 Domain
  26. 3dr1: Side-chain Fluorine Atoms of Non-steroidal Vitamin D3 Analogs Stabilize Helix 12 of Vitamin D Receptor
  27. 3dcu: Fxr with Src1 and Gsk8062
  28. 3dct: Fxr with Src1 and Gw4064
  29. 3ctb: Tethered Pxr-lbd/src-1p Apoprotein
  30. 3bqd: Doubling The Size of The Glucocorticoid Receptor Ligand Binding Pocket by Deacylcortivazol
  31. 3biy: Crystal Structure of P300 Histone Acetyltransferase Domain in Complex with a Bisubstrate Inhibitor, Lys-coa
  32. 1wgs: Solution Structure of The Tudor Domain from Mouse Hypothetical Protein Homologous to Histone Acetyltransferase
  33. 1wo3: Solution Structure of Minimal Mutant 1 (mm1): Multiple Alanine Mutant of Non-native Chance Domain
  34. 1wo4: Solution Structure of Minimal Mutant 2 (mm2): Multiple Alanine Mutant of Non-native Chance Domain
  35. 1wo5: Solution Structure of Designed Functional Finger 2 (dff2): Designed Mutant Based on Non-native Chance Domain
  36. 1wo6: Solution Structure of Designed Functional Finger 5 (dff5): Designed Mutant Based on Non-native Chance Domain
  37. 1wo7: Solution Structure of Designed Functional Finger 7 (dff7): Designed Mutant Based on Non-native Chance Domain
  38. 1wug: Complex Structure of Pcaf Bromodomain with Small Chemical Ligand Np1
  39. 1wum: Complex Structure of Pcaf Bromodomain with Small Chemical Ligand Np2
  40. 1xiu: Crystal Structure of The Agonist-bound Ligand-binding Domain of Biomphalaria Glabrata Rxr
  41. 1ygh: Hat Domain of Gcn5 from Saccharomyces Cerevisiae
  42. 1z4r: Human Gcn5 Acetyltransferase
  43. 1zaf: Crystal Structure of Estrogen Receptor Beta Complexed with 3-bromo-6-hydroxy-2-(4-hydroxy-phenyl)-inden-1-one
  44. 1zoq: Irf3-cbp Complex
  45. 1zs5: Structure-based Evaluation of Selective and Non-selective Small Molecules That Block Hiv-1 Tat and Pcaf Association
  46. 2a3i: Structural and Biochemical Mechanisms for The Specificity of Hormone Binding and Coactivator Assembly by Mineralocorticoid Receptor
  47. 7jfm: Crystal Structure of Mouse Phosphorylated Irf-3 Bound to Cbp
  48. 7jfl: Crystal Structure of Human Phosphorylated Irf-3 Bound to Cbp
  49. 7co1: Crystal Structure of Smad2 in Complex with Wild-type Cbp
  50. 7cmr: The Crystal Structure of Human Myst1 from Wuxi Biortus.
  51. 7bq4: X-ray Structure of Human Pparalpha Ligand Binding Domain- Eicosapentaenoic Acid (epa)-src1 Coactivator Peptide Co-crystals Obtained by Delipidation and Co-crystallization
  52. 7bq3: X-ray Structure of Human Pparalpha Ligand Binding Domain-gw7647-src1 Coactivator Peptide Co-crystals Obtained by Delipidation and Co- Crystallization
  53. 7bq2: X-ray Structure of Human Pparalpha Ligand Binding Domain-pemafibrate- Src1 Coactivator Peptide Co-crystals Obtained by Soaking
  54. 7bq1: X-ray Structure of Human Pparalpha Ligand Binding Domain-intrinsic Fatty Acid (e. Coli Origin)-src1 Coactivator Peptide Co-crystals Obtained by Co-crystallization
  55. 7bq0: X-ray Structure of Human Pparalpha Ligand Binding Domain-fenofibric Acid-src1 Coactivator Peptide Co-crystals Obtained by Delipidation and Co-crystallization
  56. 7bpz: X-ray Structure of Human Pparalpha Ligand Binding Domain-bezafibrate- Src1 Coactivator Peptide Co-crystals Obtained by Soaking
  57. 7bpy: X-ray Structure of Human Pparalpha Ligand Binding Domain-clofibric Acid-src1 Coactivator Peptide Co-crystals Obtained by Delipidation and Co-crystallization
  58. 6zr5: Crystal Structure of Jnk1 in Complex with Atf2(19-58)
  59. 6zqs: Crystal Structure of Double-phosphorylated P38ALPHA with Atf2(83-102)
  60. 2ro0: Solution Structure of The Knotted Tudor Domain of The Yeast Histone Acetyltransferase, Esa1
  61. 2rnz: Solution Structure of The Presumed Chromodomain of The Yeast Histone Acetyltransferase, Esa1
  62. 2rny: Complex Structures of Cbp Bromodomain with H4 Ack20 Peptide
  63. 2rnx: The Structural Basis for Site-specific Lysine-acetylated Histone Recognition by The Bromodomains of The Human Transcriptional Co-activators Pcaf and Cbp
  64. 2rnw: The Structural Basis for Site-specific Lysine-acetylated Histone Recognition by The Bromodomains of The Human Transcriptional Co-activators Pcaf and Cbp
  65. 2rc4: Crystal Structure of The Hat Domain of The Human Moz Protein
  66. 2bud: The Solution Structure of The Chromo Barrel Domain from The Males-absent on The First (mof) Protein
  67. 2c52: Structural Diversity in Cbp P160 Complexes
  68. 2pq8: Myst Histone Acetyltransferase 1
  69. 2d82: Target Structure-based Discovery of Small Molecules That Block Human P53 and Creb Binding Protein (cbp) Association
  70. 2p54: A Crystal Structure of Ppar Alpha Bound with Src1 Peptide and Gw735
  71. 2p0w: Human Histone Acetyltransferase 1 (hat1)
  72. 2ozu: Crystal Structure of Human Myst Histone Acetyltransferase 3 in Complex with Acetylcoenzyme a
  73. 2ou2: Acetyltransferase Domain of Human Hiv-1 Tat Interacting Protein, 60kda, Isoform 3
  74. 6xp9: Structure of Human Pregnane X Receptor Ligand Binding Domain Bound Tethered with Src Co-activator Peptide in Complex with (s,s)-1
  75. 6bqd: Taf1-bd2 Bromodomain in Complex with (e)-3-(6-(but-2-en-1-yl)-7-oxo-6, 7-dihydro-1h-pyrrolo[2,3-c]pyridin-4-yl)-n,n-dimethylbenzamide
  76. 6bns: Structure of Human Pregnane X Receptor Ligand Binding Domain Bound Tethered with Src Co-activator Peptide and Compound 25a Aka Bicyclic Hexafluoroisopropyl 2 Alcohol Sulfonamides
  77. 6ba4: Crystal Structure of Myst Acetyltransferase Domain in Complex with Acetyl-coa Cofactor
  78. 6ba2: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor
  79. 6ay5: Crebbp Bromodomain in Complex with Cpd17 (5-(7-(difluoromethyl)-6-(1- Methyl-1h-pyrazol-4-yl)-3,4-dihydroquinolin-1(2h)-yl)-3- Methylbenzo[d]thiazol-2(3h)-one)
  80. 6ay3: Crebbp Bromodomain in Complex with Cpd16 (5-(7-(difluoromethyl)-6-(1- Methyl-1h-pyrazol-4-yl)-3,4-dihydroquinolin-1(2h)-yl)-n-methyl-1h- Indole-3-carboxamide)
  81. 6axq: Crebbp Bromodomain in Complex with Cpd6 (methyl 1h-indole-3- Carboxylate)
  82. 2nv7: Crystal Structure of Estrogen Receptor Beta Complexed with Way-555
  83. 6alc: Crebbp Bromodomain in Complex with Cpd 4 (1-(1-(cyclopropylmethyl)-3- (1h-indol-4-yl)-1,4,6,7-tetrahydro-5h-pyrazolo[4,3-c]pyridin-5-yl) Ethan-1-one)
  84. 6alb: Crebbp Bromodomain in Complex with Cpd 30 (1-(3-(3-(1-methyl-1h- Pyrazol-4-yl)isoquinolin-8-yl)-1-(tetrahydro-2h-pyran-4-yl)-1,4,6,7- Tetrahydro-5h-pyrazolo[4,3-c]pyridin-5-yl)ethan-1-one)
  85. 2eko: Solution Structure of Ruh-073, a Pseudo Chromo Domain from Human Cdna
  86. 2fvj: A Novel Anti-adipogenic Partial Agonist of Peroxisome Proliferator-activated Receptor-gamma (pparg) Recruits Pparg-coactivator-1 Alpha (PGC1A) but Potentiates Insulin Signaling in Vitro
  87. 2giv: Human Myst Histone Acetyltransferase 1
  88. 2k8f: Structural Basis for The Regulation of P53 Function by P300
  89. 2ka6: Nmr Structure of The Cbp-taz2/stat1-tad Complex
  90. 6tfi: Pxr in Complex with Thrombin Inhibitor Compound 17
  91. 6t2m: Vdr-zk168281 Complex
  92. 6sxx: Crystal Structure of The Bromodomain of Human Crebbp in Complex with Aca007
  93. 6sqm: Crystal Structure of Crebbp Bromodomain Complexed with La36
  94. 6sqf: Crystal Structure of Crebbp Bromodomain Complexed with LB32A
  95. 6sqe: Crystal Structure of Crebbp Bromodomain Complexed with Kd341
  96. 6sqc: Crystal Structure of Complex between Nuclear Coactivator Binding Domain of Cbp and [1040-1086]actr Containing Alpha-methylated Leu1055 and Leu1076
  97. 2kje: Nmr Structure of Cbp Taz2 and Adenoviral E1A Complex
  98. 2kkj: Solution Structure of The Nuclear Coactivator Binding Domain of Cbp
  99. 6lsb: Crystal Structure of Dpf Domain of Moz in Complex with H3K14BZ Peptide
  100. 6l6k: Crystal Structure of Dimeric Rxralpha-lbd Complexed with Partial Agonist Cbt-pmn and Src1
  101. 3p1f: Crystal Structure of The Bromodomain of Human Crebbp in Complex with a Hydroquinazolin Ligand
  102. 2l84: Solution Nmr Structures of Cbp Bromodomain with Small Molecule J28
  103. 2l85: Solution Nmr Structures of Cbp Bromodomain with Small Molecule of Hbs
  104. 3q33: Structure of The Rtt109-accoa/vps75 Complex and Implications for Chaperone-mediated Histone Acetylation
  105. 3q35: Structure of The Rtt109-accoa/vps75 Complex and Implications for Chaperone-mediated Histone Acetylation
  106. 6p3a: Crystal Structure Analysis of Taf1 Bromodomain
  107. 6p39: Crystal Structure Analysis of Taf1 Bromodomain
  108. 6p38: Crystal Structure Analysis of Taf1 Bromodomain
  109. 3qm0: Crystal Structure of Rtt109-ac-coa Complex
  110. 3q66: Structure of The Vps75-rtt109 Histone Chaperone-lysine Acetyltransferase Complex (full-length Proteins in Space Group P6122)
  111. 3q68: Structure of The Vps75-rtt109 Histone Chaperone-lysine Acetyltransferase Complex (full-length Proteins in Space Group P212121)
  112. 6w9i: Substituted Benzyloxytricyclic Compounds as Retinoic Acid-related Orphan Receptor Gamma T Agonists
  113. 6w9h: Substituted Benzyloxytricyclic Compounds as Retinoic Acid-related Orphan Receptor Gamma T Agonists
  114. 6yim: Crystal Structure of The Crebbp Bromodomain in Complex with a Benzo- Diazepine Ligand
  115. 6yil: Crystal Structure of The Crebbp Bromodomain in Complex with a Tetrahydroquinoxaline Ligand
  116. 6yik: Crystal Structure of The Crebbp Bromodomain in Complex with a Tetrahydroquinoxaline Ligand
  117. 6yij: Crystal Structure of The Crebbp Bromodomain in Complex with a Benzo- Diazepine Ligand
  118. 2kwf: The Structure of E-protein Activation Domain 1 Bound to The Kix Domain of Cbp/p300 Elucidates Leukemia Induction by E2A-PBX1
  119. 6v90: Crystal Structure of The P300 Acetyltransferase Domain with Accoa Competitive Inhibitor 12
  120. 6v8n: Crystal Structure of The P300 Acetyltransferase Domain with Accoa Competitive Inhibitor 17
  121. 6v8k: Crystal Structure of The P300 Acetyltransferase Domain with Peptide- Competitive Inhibitor 2
  122. 6v8b: Crystal Structure of The P300 Acetyltransferase Domain with Accoa Competitive Inhibitor 1
  123. 6pdg: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 83
  124. 6pdf: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 55
  125. 6pde: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 40
  126. 6pdd: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 41
  127. 6pdc: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 42
  128. 6pdb: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 80
  129. 6pda: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 74
  130. 6pd9: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 60
  131. 6pd8: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 39
  132. 6owi: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 85
  133. 6owh: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 92
  134. 6qst: Structure of Crebbp Bromodomain with Compound 2 Bound
  135. 3qah: Crystal Structure of Apo-form Human Mof Catalytic Domain
  136. 6vo5: Crystal Structure of Human Histone Acetytransferas 1 (hat1) in Complex with Isobutryl-coa and K12A Mutant Variant of Histone H4
  137. 3p57: Crystal Structure of The P300 Taz2 Domain Bound to Mef2 on Dna
  138. 3r8d: Activation of The Human Nuclear Xenobiotic Receptor Pxr by The Reverse Transcriptase-targeted Anti-hiv Drug Pnu-142721
  139. 6mak: Hbo1 Is Required for The Maintenance of Leukaemia Stem Cells
  140. 6maj: Hbo1 Is Required for The Maintenance of Leukaemia Stem Cells
  141. 3p89: Fxr Bound to a Quinolinecarboxylic Acid
  142. 3rut: Fxr with Src1 and Gsk359
  143. 3ruu: Fxr with Src1 and Gsk237
  144. 3rvf: Fxr with Src1 and Gsk2034
  145. 6u25: Crystal Structure of Rar-related Orphan Receptor C (nhis- Rorgt(244- 487)-l6-src1(678-692)) in Complex with a Tricyclic Inverse Agonist
  146. 6ssq: Crystal Structure of Rarbeta Lbd in Complex with Lg 100754
  147. 3to6: Crystal Structure of Yeast Esa1 Hat Domain Complexed with H4K16COA Bisubstrate Inhibitor
  148. 3to7: Crystal Structure of Yeast Esa1 Hat Domain Bound to Coenzyme a with Active Site Lysine Acetylated
  149. 3to9: Crystal Structure of Yeast Esa1 E338Q Hat Domain Bound to Coenzyme a with Active Site Lysine Acetylated
  150. 3toa: Human Mof Crystal Structure with Active Site Lysine Partially Acetylated
  151. 3tob: Human Mof E350Q Crystal Structure with Active Site Lysine Partially Acetylated
  152. 6qpj: Human Clock Pas-a Domain
  153. 6qk7: Elongator Catalytic Subcomplex Elp123 Lobe
  154. 4a9k: Bromodomain of Human Crebbp with N-(4-hydroxyphenyl) Acetamide
  155. 6pgu: Crystal Structure of The P300 Acetyltransferase Domain with Allosteric Inhibitor Cpi-076 and Coa
  156. 6pf1: Crystal Structure of The P300 Acetyltransferase Domain with Allosteric Inhibitor Cpi-090 and Coa
  157. 3qt0: Revealing a Steroid Receptor Ligand as a Unique Ppargamma Agonist
  158. 6p9f: Crystal Structure of Rar-related Orphan Receptor C (nhis-rorgt(244- 487)-l6-src1(678-692)) in Complex with a Phenyl (3-phenylpyrrolidin- 3-yl)sulfone Inhibitor
  159. 6oir: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 62
  160. 6oiq: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 63
  161. 6oip: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 34
  162. 6oio: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 60
  163. 6oin: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor Ctx-124143
  164. 6oie: The Double Phd Finger (dpf) of Morf in Complex with Histone H3K14CR
  165. 4dm6: Crystal Structure of Rarb Lbd Homodimer in Complex with Ttnpb
  166. 4dm8: Crystal Structure of Rarb Lbd in Complex with 9cis Retinoic Acid
  167. 4dma: Crystal Structure of Era Lbd in Complex with Ru100132
  168. 6o9l: Human Holo-pic in The Closed State
  169. 4dk7: Crystal Structure of Lxr Ligand Binding Domain in Complex with Full Agonist 1
  170. 4dk8: Crystal Structure of Lxr Ligand Binding Domain in Complex with Partial Agonist 5
  171. 6o22: Structure of Asf1-h3:h4-rtt109-vps75 Histone Chaperone-lysine Acetyltransferase Complex with The Histone Substrate.
  172. 2lqh: Nmr Structure of FOXO3A Transactivation Domains (CR2C-CR3) in Complex with Cbp Kix Domain (2B3L Conformation)
  173. 2lqi: Nmr Structure of FOXO3A Transactivation Domains (CR2C-CR3) in Complex with Cbp Kix Domain (2L3B Conformation)
  174. 3t03: Crystal Structure of Ppar Gamma Ligand Binding Domain in Complex with a Novel Partial Agonist Gq-16
  175. 6mzl: Human Tfiid Canonical State
  176. 6mzd: Human Tfiid Lobe a Canonical
  177. 4f3l: Crystal Structure of The Heterodimeric Clock:bmal1 Transcriptional Activator Complex
  178. 2ln0: Structure of Moz
  179. 3v43: Crystal Structure of Moz
  180. 4dnc: Crystal Structure of Human Mof in Complex with Msl1
  181. 3t92: Crystal Structure of The Taz2:c/ebpepsilon-tad Chimera Protein
  182. 6k4n: Cryo-em Structure of P300
  183. 3uu7: Crystal Structure of Hera-lbd (Y537S) in Complex with Bisphenol-a
  184. 3uua: Crystal Structure of Hera-lbd (Y537S) in Complex with Bisphenol-af
  185. 3uud: Crystal Structure of Hera-lbd (Y537S) in Complex with Estradiol
  186. 6jq7: The Ligand-free Structure of Human Ppargamma Lbd in The Presence of The Src-1 Coactivator Peptide
  187. 6j3p: Crystal Structure of The Human Gcn5 Bromodomain in Complex with Compound (r,r)-36n
  188. 6j3o: Crystal Structure of The Human Pcaf Bromodomain in Complex with Compound 12
  189. 4g1y: Structural Basis for The Accommodation of Bis- and Tris-aromatic Derivatives in Vitamin D Nuclear Receptor
  190. 4g1z: Structural Basis for The Accommodation of Bis- and Tris-aromatic Derivatives in Vitamin D Nuclear Receptor
  191. 4g20: Structural Basis for The Accommodation of Bis- and Tris-aromatic Derivatives in Vitamin D Nuclear Receptor
  192. 4g21: Structural Basis for The Accommodation of Bis- and Tris-aromatic Derivatives in Vitamin D Nuclear Receptor
  193. 4g2h: Structural Basis for The Accommodation of Bis- and Tris-aromatic Derivatives in Vitamin D Nuclear Receptor
  194. 6itm: Crystal Structure of Fxr in Complex with Agonist Xj034
  195. 4dqm: Revealing a Marine Natural Product as a Novel Agonist for Retinoic Acid Receptors with a Unique Binding Mode and Antitumor Activity
  196. 6ilq: Crystal Structure of Ppargamma with Compound Br101549
  197. 6ijs: Human Ppargamma Ligand Binding Domain Complexed with Sb1494
  198. 6ijr: Human Ppargamma Ligand Binding Domain Complexed with Sb1495
  199. 6if4: Crystal Structure of Tbtudor
  200. 6icj: Crystal Structure of Ppargamma with Compound BR102375K
  201. 6iaz: The Archaeal Methanocaldococcus Infernus Elp3 with N-terminus Deletion (1-46)
  202. 6iad: Apo Crystal Structure of Archaeal Methanocaldococcus Infernus Elp3 (del1-54)
  203. 6ia8: Apo Crystal Structure of Archaeal Methanocaldococcus Infernus Elp3 (del1-19)
  204. 4h10: Intermolecular Recognition Revealed by The Complex Structure of Human Clock-bmal1 Basic Helix-loop-helix Domains with E-box Dna
  205. 6hty: Pxr in Complex with P2X4 Inhibitor Compound 25
  206. 6gyt: Transcription Factor Dimerization Activates The P300 Acetyltransferase
  207. 6gyr: Transcription Factor Dimerization Activates The P300 Acetyltransferase
  208. 4fgy: Identification of a Unique Ppar Ligand with an Unexpected Binding Mode and Antibetic Activity
  209. 4i9o: Crystal Structure of Gackix L664C Tethered to 1-10
  210. 6gg8: Mineralocorticoid Receptor in Complex with (s)-13
  211. 6gev: Mineralocorticoid Receptor in Complex with (s)-13
  212. 2lxs: Allosteric Communication in The Kix Domain Proceeds through Dynamic Re-packing of The Hydrophobic Core
  213. 2lxt: Allosteric Communication in The Kix Domain Proceeds through Dynamic Re-packing of The Hydrophobic Core
  214. 4bcr: Structure of Pparalpha in Complex with Wy14643
  215. 6frf: Crystal Structure of Crebbp Bromodomain Complexd with Pa10
  216. 6fr0: Crystal Structure of Crebbp Bromodomain Complexd with Pb08
  217. 6fqu: Crystal Structure of Crebbp Bromodomain Complexd with Dr09
  218. 6fqt: Crystal Structure of Crebbp Bromodomain Complexd with Dr46
  219. 6fqo: Crystal Structure of Crebbp Bromodomain Complexd with Dt29
  220. 6fo7: Vitamin D Nuclear Receptor Complex 3
  221. 6fic: Bivalent Inhibitor Unc4512 Bound to The Taf1 Bromodomain Tandem
  222. 6fgs: Solution Structure of P300TAZ2-P73TA1
  223. 6fgn: Solution Structure of P300TAZ2-P63TA
  224. 4b0a: The High-resolution Structure of Ytbp-ytaf1 Identifies Conserved and Competing Interaction Surfaces in Transcriptional Activation
  225. 6f0y: Rtt109 Peptide Bound to Asf1
  226. 6es7: Structure and Dynamics Conspire in The Evolution of Affinity between Intrinsically Disordered Proteins
  227. 6nx1: Structure of Human Pregnane X Receptor Ligand Binding Domain Bound Tethered with Src Co-activator Peptide and Compound-3 Aka 1,1,1,3,3, 3-hexafluoro-2-{4-[1-(4- Luorobenzenesulfonyl) Cyclopentyl]phenyl}propan-2-ol
  228. 2lww: Nmr Structure of Rela-tad/cbp-taz1 Complex
  229. 6e24: Ternary Structure of C-myc-tbp-taf1
  230. 6e16: Ternary Structure of C-myc-tbp-taf1
  231. 6ds6: Crystal Structure of P300 Zz Domain in Complex with Histone H3 Peptide
  232. 6dnq: Hbz77 in Complex with Kix and C-myb
  233. 6dmx: Hbz56 in Complex with Kix and C-myb
  234. 6dmk: A Multiconformer Ligand Model of an Isoxazolyl-benzimidazole Ligand Bound to The Bromodomain of Human Crebbp
  235. 2mh0: Solution Nmr Structure of The P300 Taz2:etad1 Complex
  236. 6cw3: Crystal Structure of a Yeast Saga Transcriptional Coactivator Ada2/gcn5 Hat Subcomplex, Crystal Form 2
  237. 6cw2: Crystal Structure of a Yeast Saga Transcriptional Coactivator Ada2/gcn5 Hat Subcomplex, Crystal Form 1
  238. 6ct2: Myst Histone Acetyltransferase KAT6A/B in Complex with Wm-1119
  239. 4bhw: Structural Basis for Autoinhibition of The Acetyltransferase Activity of P300
  240. 4j5w: Crystal Structure of The Apo-pxr/rxralpha Lbd Heterotetramer Complex
  241. 4j5x: Crystal Structure of The Sr12813-bound Pxr/rxralpha Lbd Heterotetramer Complex
  242. 4jyg: Crystal Structure of Rarbeta Lbd in Complex with Agonist Bms411 [4- {[(5,5-dimethyl-8-phenyl-5,6-dihydronaphthalen-2-yl) Carbonyl]amino}benzoic Acid]
  243. 4jyh: Crystal Structure of Rarbeta Lbd in Complex with Selective Agonist Bms948 [4-{[(8-phenylnaphthalen-2-yl)carbonyl]amino}benzoic Acid]
  244. 4jyi: Crystal Structure of Rarbeta Lbd in Complex with Selective Partial Agonist Bms641 [3-chloro-4-[(e)-2-(5,5-dimethyl-8-phenyl-5,6- Dihydronaphthalen-2-yl)ethenyl]benzoic Acid]
  245. 4ljn: Crystal Structure of Moz Double Phd Finger
  246. 4lk9: Crystal Structure of Moz Double Phd Finger Histone H3 Tail Complex
  247. 4lka: Crystal Structure of Moz Double Phd Finger Histone H3K9AC Complex
  248. 4llb: Crystal Structure of Moz Double Phd Finger Histone H3K14AC Complex
  249. 4n3w: Crystal Structure of The Bromodomain-phd Finger Module of Human Transcriptional Co-activator Cbp in Complex with Acetylated Histone 4 Peptide (H4K20AC).
  250. 4n4f: Crystal Structure of The Bromodomain-phd Finger Module of Human Transcriptional Co-activator Cbp in Complex with Di-acetylated Histone 4 Peptide (H412ACK16AC).
  251. 4nr4: Crystal Structure of The Bromodomain of Human Crebbp in Complex with an Isoxazolyl-benzimidazole Ligand
  252. 4nr5: Crystal Structure of The Bromodomain of Human Crebbp in Complex with an Isoxazolyl-benzimidazole Ligand
  253. 4nr6: Crystal Structure of The Bromodomain of Human Crebbp in Complex with an Oxazepin Ligand
  254. 4nr7: Crystal Structure of The Bromodomain of Human Crebbp in Complex with an Isoxazolyl-benzimidazole Ligand
  255. 4nsq: Crystal Structure of Pcaf
  256. 4ouf: Crystal Structure of Cbp Bromodomain
  257. 4oy2: Crystal Structure of Taf1-taf7, a Tfiid Subcomplex
  258. 5ycp: Human Ppargamma Ligand Binding Domain Complexed with Rosiglitazone
  259. 5ycn: Human Ppargamma Ligand Binding Domain Complexed with Lobeglitazone
  260. 5y7w: Crystal Structure of The Nco-a1 Pas-b Domain with Yl-2
  261. 5xzc: Cryo-em Structure of P300-p53 Protein Complex
  262. 5xxh: Crystal Structure Analysis of The Cbp
  263. 4psw: Crystal Structure of Histone Acetyltransferase Complex
  264. 4psx: Crystal Structure of Histone Acetyltransferase Complex
  265. 4pzr: Crystal Structure of P300 Histone Acetyltransferase Domain in Complex with Coenzyme a
  266. 4pzs: Crystal Structure of P300 Histone Acetyltransferase Domain in Complex with Acetyl-coenzyme a
  267. 4pzt: Crystal Structure of P300 Histone Acetyltransferase Domain in Complex with an Inhibitor, Acetonyl-coenzyme a
  268. 5x8w: Crystal Structure of The Mutant Human Ror Gamma Ligand Binding Domain.
  269. 5x8u: Crystal Structure of The Wild Human Ror Gamma Ligand Binding Domain.
  270. 5x0r: Crystal Structure of Pxr Lbd Complexed with Sjb7
  271. 5wci: Human Myst Histone Acetyltransferase 1
  272. 5w0q: Crebbp Bromodomain in Complex with Cpd17 (n,2,7-trimethyl-2,3-dihydro- 4h-benzo[b][1,4]oxazine-4-carboxamide)
  273. 5w0l: Crebbp Bromodomain in Complex with Cpd10 (1-(3-(7-(difluoromethyl)-6- (1-methyl-1h-pyrazol-4-yl)-3,4-dihydroquinolin-1(2h)-yl)-1- (tetrahydro-2h-pyran-4-yl)-1,4,6,7-tetrahydro-5h-pyrazolo[4,3- C]pyridin-5-yl)ethan-1-one)
  274. 4qqg: Crystal Structure of an N-terminal Htatip Fragment
  275. 5w0i: Crebbp Bromodomain in Complex with Cpd8 (1-(3-(7-(difluoromethyl)-6- (1-methyl-1h-pyrazol-4-yl)-3,4-dihydroquinolin-1(2h)-yl)-1- (tetrahydrofuran-3-yl)-1,4,6,7-tetrahydro-5h-pyrazolo[4,3-c]pyridin- 5-yl)ethan-1-one)
  276. 5w0f: Crebbp Bromodomain in Complex with Cpd3 ((s)-1-(3-(6-(1-methyl-1h- Pyrazol-4-yl)-3,4-dihydroquinolin-1(2h)-yl)-1-(tetrahydrofuran-3-yl)- 1,4,6,7-tetrahydro-5h-pyrazolo[4,3-c]pyridin-5-yl)ethan-1-one)
  277. 5w0e: Crebbp Bromodomain in Complex with Cpd19 (3-(7-(difluoromethyl)-6-(1- Methyl-1h-pyrazol-4-yl)-3,4-dihydroquinolin-1(2h)-yl)-n-methyl-1- (tetrahydro-2h-pyran-4-yl)-1,4,6,7-tetrahydro-5h-pyrazolo[4,3- C]pyridine-5-carboxamide)
  278. 6ktm: The Ligand-free Structure of Human Ppargamma Ligand-binding Domain R288A Mutant in The Presence of The Src-1 Coactivator Peptide
  279. 6ktn: Human Ppargamma Ligand-binding Domain R288A Mutant in Complex with Imatinib
  280. 5vjx: Crystal Structure of The Clock Transcription Domain Exon19 in Complex with a Repressor
  281. 5vji: Crystal Structure of The Clock Transcription Domain Exon19 in Complex with a Repressor
  282. 4rgw: Crystal Structure of a Taf1-taf7 Complex in Human Transcription Factor Iid
  283. 5u2j: Morf Double Phd Finger (dpf) in Complex with Histone H3K14BU
  284. 5trm: Crystal Structure of Human Gcn5 Histone Acetyltransferase Domain
  285. 5trl: Crystal Structure of Human Gcn5 Histone Acetyltransferase Domain
  286. 5tpx: Bromodomain from Plasmodium Faciparum Gcn5, Complexed with Compound
  287. 5tb6: Structure of Bromodomain of Crebbp with a Pyrazolo[4,3-c]pyridin Fragment
  288. 5svh: Crystal Structure of The Kix Domain of Cbp in Complex with a Mll/c-myb Chimera
  289. 5owk: Crystal Structure of Crebbp Bromodomain Complexed with DSPB2A002
  290. 5owd: Vitamin D Receptor Complex
  291. 5ow9: Vitamin D Receptor Complex
  292. 5ow7: Vdr Complex
  293. 5nwx: Insight into The Molecular Recognition Mechanism of The Coactivator Ncoa1 by Stat6
  294. 5nwm: Insight into The Molecular Recognition Mechanism of The Coactivator Ncoa1 by Stat6
  295. 5nu5: Crystal Structure of The Human Bromodomain of Ep300 Bound to The Inhibitor Xdm-cbp
  296. 5nu3: Crystal Structure of The Human Bromodomain of Crebbp Bound to The Inhibitor Xdm-cbp
  297. 5nrw: Crystal Structure of The Human Bromodomain of Crebbp Bound to The Inhibitor Xdm4
  298. 5nma: Structure-activity Relationship Study of Vitamin D Analogs with Oxolane Group in Their Side Chain
  299. 5nlk: Crystal Structure of Crebbp Bromodomain Complexd with US13A
  300. 5mqk: Crystal Structure of Crebbp Bromodomain Complexed with Cbp019
  301. 5mqg: Crystal Structure of Crebbp Bromodomain Complexed with Cbp015
  302. 5mqe: Crystal Structure of Crebbp Bromodomain Complexed with Cbp006
  303. 5mpz: Crystal Structure of Crebbp Bromodomain Complexed with Cbp007
  304. 5mpn: Crystal Structure of Crebbp Bromodomain Complexed with Fa26
  305. 5mpk: Crystal Structure of Crebbp Bromodomain Complexed with Dk19
  306. 5mmg: Crystal Structure of Crebbp Bromodomain Complexed with UT07C
  307. 5mme: Crystal Structure of Crebbp Bromodomain Complexd with US46C
  308. 5mlj: Bromodomain of Human Gcn5 with 4-bromo-2-methyl-5-(((3r,5r)-1-methyl- 5-phenylpiperidin-3-yl)amino)pyridazin-3(2h)-one
  309. 5ml0: Bromodomain of Mouse Pcaf with (r)-4-chloro-2-methyl-5-((1- Methylpiperidin-3-yl)amino)pyridazin-3(2h)-one
  310. 5mkx: 1.68a Structure Pcaf Bromodomain with 4-chloro-2-methyl-5- (methylamino)pyridazin-3(2h)-one
  311. 5mg2: Crystal Structure of The Second Bromodomain of Human Taf1 in Complex with Bay-299 Chemical Probe
  312. 5lvr: Crystal Structure of Human Pcaf Bromodomain in Complex with Compound-e (cpd-e)
  313. 5lvq: Crystal Structure of Human Pcaf Bromodomain in Complex with Compound-d (cpd-d), N-methyl-2-(tetrahydro-2h-pyran-4-yloxy)benzamide
  314. 5lpm: Crystal Structure of The Bromodomain of Human Ep300 Bound to The Inhibitor XDM3D
  315. 5lpl: Crystal Structure of The Bromodomain of Human Crebbp Bound to The Inhibitor XDM3C
  316. 5lpk: Crystal Structure of The Bromodomain of Human Ep300 Bound to The Inhibitor Xdm1
  317. 5lpj: Crystal Structure of The Bromodomain of Human Crebbp Bound to The Inhibitor Xdm1
  318. 5lkz: Crystal Structure of The P300 Acetyltransferase Catalytic Core with Crotonyl-coenzyme A.
  319. 5lkx: Crystal Structure of The P300 Acetyltransferase Catalytic Core with Propionyl-coenzyme A.
  320. 5lku: Crystal Structure of The P300 Acetyltransferase Catalytic Core with Coenzyme A.
  321. 5lkt: Crystal Structure of The P300 Acetyltransferase Catalytic Core with Butyryl-coenzyme A.
  322. 5ktx: Crebbp Bromodomain in Complex with Cpd59 ((s)-1-(3-((2-fluoro-4-(1- Methyl-1h-pyrazol-4-yl)phenyl)amino)-1-(tetrahydrofuran-3-yl)-6,7- Dihydro-1h-pyrazolo[4,3-c]pyridin-5(4h)-yl)ethanone)
  323. 5ktw: Crebbp Bromodomain in Complex with Cpd 44 (3-((5-acetyl-1- (cyclopropylmethyl)-4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridin-3- Yl)amino)-n-isopropylbenzamide)
  324. 5ktu: Crystal Structure of The Bromodomain of Human Crebbp Bound to Pyrazolopiperidine Scaffold
  325. 5kj2: The Novel P300/cbp Inhibitor A-485 Uncovers a Unique Mechanism of Action to Target Ar in Castrate Resistant Prostate Cancer
  326. 5jmm: Crystal Structure of Hera-lbd (Y537S) in Complex with Biochanin a
  327. 5ji0: PPARGAMMA-RXRALPHA(S427F) Heterodimer in Complex with Src-1, Rosiglitazone, and 9-cis-retanoic Acid
  328. 5jem: Complex of Irf-3 with Cbp
  329. 5j9w: Crystal Structure of The Nua4 Core Complex
  330. 5j9u: Crystal Structure of The Nua4 Core Complex
  331. 5j9t: Crystal Structure of The Nua4 Core Complex
  332. 5j9q: Crystal Structure of The Nua4 Core Complex
  333. 5j8f: Human Mof K274P Crystal Structure
  334. 5j8c: Human Mof C316S, E350Q Crystal Structure
  335. 5j0d: Crystal Structure of The Bromodomain of Human Crebbp in Complex with a Benzoxazepine Compound
  336. 5icw: Crystal Structure of Human Natf (hnaa60) Homodimer Bound to Coenzyme a
  337. 5icv: Crystal Structure of Human Natf (hnaa60) Bound to a Bisubstrate Analogue
  338. 5i8g: Cbp in Complex with Cpd637 ((r)-4-methyl-6-(1-methyl-3-(1-methyl-1h- Pyrazol-4-yl)-1h-indazol-5-yl)-1,3,4,5-tetrahydro-2h-benzo[b][1, 4]diazepin-2-one)
  339. 5i8b: Cbp in Complex with Cpd23 ((r)-6-(3-(benzyloxy)phenyl)-4-methyl-1,3,4, 5-tetrahydro-2h-benzo[b][1,4]diazepin-2-one)
  340. 5hpd: Solution Structure of TAZ2-P53TAD
  341. 5hp0: Solution Structure of TAZ2-P53AD2
  342. 5hou: Solution Structure of P53TAD-TAZ1
  343. 5hjs: Identification of Lxrbeta Selective Agonists for The Treatment of Alzheimer's Disease
  344. 5hh1: Crystal Structure of Human Naa60 Mutant - F34A in Complex with Coa
  345. 5hh0: Crystal Structure of Human Naa60 in Complex with Coa
  346. 5hgz: Crystal Structure of Human Naa60 in Complex with Acetyl-coa
  347. 5h86: Human Gcn5 Bound to Butyryl-coa
  348. 5h85: Crystal Structure of The Bromodomain of Human Crebbp in Complex with UO37D
  349. 5h84: Human Gcn5 Bound to Propionyl-coa
  350. 5h43: Structural and Mechanistical Studies of The Nuclear Import by Importin-alpha
  351. 5gk9: Crystal Structure of Human Hbo1 in Complex with Brpf2
  352. 5fur: Structure of Human Tfiid-iia Bound to Core Promoter Dna
  353. 5fe9: Crystal Structure of Human Pcaf Bromodomain in Complex with Compound Sl1122 (compound 13)
  354. 5fe8: Crystal Structure of Human Pcaf Bromodomain in Complex with Compound Sl1126 (compound 12)
  355. 5fe7: Crystal Structure of Human Pcaf Bromodomain in Complex with Fragment Zb2216 (fragment 11)
  356. 5fe6: Crystal Structure of Human Pcaf Bromodomain in Complex with Fragment Zb1916 (fragment 10)
  357. 5fe5: Crystal Structure of Human Pcaf Bromodomain in Complex with Fragment Mb093 (fragment 7)
  358. 5fe4: Crystal Structure of Human Pcaf Bromodomain in Complex with Fragment Mb364 (fragment 5)
  359. 5fe3: Crystal Structure of Human Pcaf Bromodomain in Complex with Fragment Mb360 (fragment 4)
  360. 5fe2: Crystal Structure of Human Pcaf Bromodomain in Complex with Fragment Br013 (fragment 3)
  361. 5fe1: Crystal Structure of Human Pcaf Bromodomain in Complex with Fragment Br004 (fragment 1)
  362. 5fe0: Crystal Structure of Human Pcaf Bromodomain in Complex with Acetyllysine
  363. 5fdz: Crystal Structure of Human Pcaf Bromodomain in Complex with Compound BDOMB00091A (compound 14)
  364. 5ep7: Crystal Structure of The Bromodomain of Human Crebbp in Complex with Un32
  365. 5eng: Crystal Structure of The Bromodomain of Human Crebbp in Complex with Up39
  366. 5eic: Crystal Structure of The Bromodomain of Human Crebbp in Complex with Ayc
  367. 5dwl: Human Ppargamma Ligand Binding Dmain in Complex with Sr1664
  368. 5dvc: Human Ppargamma Ligand Binding Dmain Complexed with Sb1453 in a Covalent Bonded Form
  369. 5dv8: Human Ppargamma Ligand Binding Dmain Complexed with Sb1451 in a Covalent Bonded Form
  370. 5dv6: Human Ppargamma Ligand Binding Dmain Complexed with Sb1404 in a Covalent Bonded Form
  371. 5dv3: Human Ppargamma Ligand Binding Dmain Complexed with Sb1405 in a Covalent Bonded Form
  372. 5dsh: Human Ppargamma Ligand Binding Dmain Complexed with Sb1406 in a Covalent Bonded Form
  373. 5dbm: Crystal Structure of The Cbp Bromodomain in Complex with Cpi703
  374. 5cgp: Selective Pharmacological Inhibition of The Creb Binding Protein Bromodomain Regulates Inflammatory Cytokines in Macrophages and Rgs4 in Neurons
  375. 4ci4: Structural Basis for Gl479 a Dual Peroxisome Proliferator- Activated Receptor Alpha Agonist
  376. 5bt3: Crystal Structure of Ep300 Bromodomain in Complex with Sgc-cbp30 Chemical Probe
  377. 5b78: Crystal Structure of Moz Double Phd Finger MUTANT-S210D/N235R in Complex with Histone H3 Crotonylation at K14
  378. 5b77: Crystal Structrue of Moz Double Phd Finger in Complex with Histone H3 Propionylation at K14
  379. 5b76: Crystal Structure of Moz Double Phd Finger Domain in Complex with Histone H3 Crotonylation at K14
  380. 5b75: Crystal Structure of Moz Double Phd Finger in Complex with Histone H3 Butyrylation at K14
  381. 5avl: Crystal Structure of Lxralpha in Complex with Tert-butyl Benzoate Analog, Compound 32b
  382. 5avi: Crystal Structure of Lxralpha in Complex with Tert-butyl Benzoate Analog, Compound 4
  383. 5a86: Structure of Pregnane X Receptor in Complex with a Sphingosine 1- Phosphate Receptor 1 Antagonist
  384. 4tuz: Crystal Structure of Hera-lbd (Y537S) in Complex with Alpha-zearalenol
  385. 4tv1: Crystal Structure of Hera-lbd (Y537S) in Complex with Propylparaben
  386. 2mzd: Characterization of The P300 Taz2-p53 Tad2 Complex and Comparison with The P300 Taz2-p53 Tad1 Complex
  387. 4yk0: Crystal Structure of The Cbp Bromodomain in Complex with Cpi098
  388. 2n1a: Docked Structure between Sumo1 and Zz-domain from Cbp
  389. 4tqn: Crystal Structure of The Bromodomain of Human Crebbp in Complex with Ul04
  390. 4ts8: Crystal Structure of The Bromodomain of Human Crebbp in Complex with Xz08
  391. 4uda: Mr in Complex with Dexamethasone
  392. 4udb: Mr in Complex with Desisobutyrylciclesonide
  393. 4whu: Bromo Domain of Creb Binding Protein
  394. 7kxd: Crystal Structure of Rar-related Orphan Receptor C (nhis-rorgt(244- 487)-l6-src1(678-692)) in Complex with {3,5-dichloro-4-[4-methoxy-3- (propan-2-yl)phenoxy]phenyl}methanol
  395. 7kxe: Crystal Structure of Rar-related Orphan Receptor C (nhis-rorgt(244- 487)-l6-src1(678-692)) in Complex with {3,5-dichloro-4-[4-methoxy-3- (propan-2-yl)phenoxy]phenyl}methanol
  396. 7kxf: Crystal Structure of Rar-related Orphan Receptor C (nhis-rorgt(244- 487)-l6-src1(678-692)) in Complex with {3,5-dichloro-4-[4-methoxy-3- (propan-2-yl)phenoxy]phenyl}methanol
  397. 7jjh: Crystal Structure of The Unliganded Tandem Bromodomain (bd1, Bd2) of Human Taf1
  398. 7lje: Discovery of Spirohydantoins as Selective, Orally Bioavailable Inhibitors of P300/cbp Histone Acetyltransferases
  399. 7bwz: Crystal Structure of Rtt109 from Candida Albicans
  400. 7bx0: Crystal Structure of Rtt109 from Candida Albicans
  401. 7bx1: Crystal Structure of Rtt109 from Candida Albicans
  402. 7bxw: Crystal Structure off Rtt109 from Candida Albicans
  403. 7edx: P53-bound Tfiid-based Core Pic on Hdm2 Promoter
  404. 7eg7: Tfiid-based Core Pic on Scp Promoter
  405. 7eg8: Tfiid-based Core Pic on Puma Promoter
  406. 7eg9: Tfiid-based Intermediate Pic on Scp Promoter
  407. 7ega: Tfiid-based Intermediate Pic on Puma Promoter
  408. 7nvr: Human Mediator with Rna Polymerase II Pre-initiation Complex
  409. 7nvs: Rna Polymerase II Core Pre-initiation Complex with Closed Promoter Dna in Proximal Position
  410. 7nvt: Rna Polymerase II Core Pre-initiation Complex with Closed Promoter Dna in Distal Position
  411. 7nvu: Rna Polymerase II Core Pre-initiation Complex with Open Promoter Dna
  412. 7nvy: Rna Polymerase II Pre-initiation Complex with Closed Promoter Dna in Proximal Position
  413. 7nvz: Rna Polymerase II Pre-initiation Complex with Closed Promoter Dna in Distal Position
  414. 7nw0: Rna Polymerase II Pre-initiation Complex with Open Promoter Dna
  415. 7egd: Scp Promoter-bound Tfiid-tfiia in Initial Tbp-loading State
  416. 7ege: Tfiid in Canonical Conformation
  417. 7egh: Tfiid Lobe C Subcomplex
  418. 7egi: Tfiid in Rearranged Conformation
  419. 7egj: Scp Promoter-bound Tfiid-tfiia in post Tbp-loading State
  420. 7c3o: Crystal Structure of Tt109 from Candida Albicans
  421. 7kpy: Crystal Structure of Cbp Bromodomain Liganded with Umb298 (compound 23)
  422. 7n42: Crystal Structure of The Tandem Bromodomain of Human Taf1 (taf1-t) Bound to Zs1-681
  423. 7l6x: Crystal Structure of The Tandem Bromodomain (bd1, Bd2) of Human Taf1 Bound to Gne-371
  424. 7chg: The Structure of Human Pregnane X Receptor in Complex with an Src-1 Coactivator Peptide and a Limonoid Compound
  425. 7d0o: Crystal Structure of Human Hbo1-brpf2 in Apo Form
  426. 7d0p: Crystal Structure of Human Hbo1-brpf2 in Complex with Propionyl- Coenzyme a
  427. 7d0q: Crystal Structure of Human Hbo1-brpf2 in Complex with Butyryl-coenzyme a
  428. 7d0r: Crystal Structure of Human Hbo1-brpf2 in Complex with Crotonoyl- Coenzyme a
  429. 7d0s: Crystal Structure of Human Hbo1-brpf2 in Complex with Succinyl- Coenzyme a
  430. 7lb0: Crystal Structure of The Tandem Bromodomain (bd1, Bd2) of Human Taf1 Bound to Zs1-295
  431. 7lb1: Crystal Structure of The Tandem Bromodomain (bd1, Bd2) of Human Taf1 Bound to Zs1-585
  432. 7lb2: Crystal Structure of The Tandem Bromodomain (bd1, Bd2) of Human Taf1 Bound to Zs1-589
  433. 7jjg: Crystal Structure of The Second Bromodomain (bd2) of Human Taf1 Bound to Atr Kinase Inhibitor Az20
  434. 7lvs: The Cbp Taz1 Domain in Complex with a Cited2-hif-1-alpha Fusion Peptide
  435. 7aos: Crystal Structure of The Raralpha/rxralpha Ligand Binding Domain Heterodimer in Complex with a Fragment of Src1 Coactivator
  436. 7bo6: Vdr Complex with Lca Derivative
  437. 7jsp: Crystal Structure of The Second Bromodomain (bd2) of Human Taf1 Bound to Atr Kinase Inhibitor Azd6738
  438. 7jtc: Crystal Structure of The Second Bromodomain (bd2) of Human Taf1 Bound to Zs1-322
  439. 7b39: Allene-based Design of a Noncalcemic Vitamin D Receptor Agonist
  440. 7cxf: The Ligand-free Structure of Human Ppargamma Lbd C285Y Mutant in The Presence of The Src-1 Coactivator Peptide
  441. 7cxh: The Ligand-free Structure of Human Ppargamma Lbd Q286E Mutant in The Presence of The Src-1 Coactivator Peptide
  442. 7cxi: The Ligand-free Structure of Human Ppargamma Lbd F287Y Mutant in The Presence of The Src-1 Coactivator Peptide
  443. 7cxj: The Ligand-free Structure of Human Ppargamma Lbd R288C Mutant in The Presence of The Src-1 Coactivator Peptide
  444. 7cxk: The Ligand-free Structure of Human Ppargamma Lbd R288H Mutant in The Presence of The Src-1 Coactivator Peptide
  445. 7cxl: The Ligand-free Structure of Human Ppargamma Lbd S289C Mutant in The Presence of The Src-1 Coactivator Peptide
  446. 7juo: Cbp Bromodomain Complexed with Yf2-23
  447. 7oxz: Vdr Complex with a Side-chain Hydroxylated Derivative of Lithocholic Acid
  448. 7oy4: Vdr Complex of a Side-chain Hydroxylated Derivatives of Lithocholic Acid
  449. 7k03: Crystal Structure of The Tandem Bromodomain (bd1 and Bd2) of Human Taf1 Bound to Atr Kinase Inhibitor Azd6738
  450. 7k0d: Crystal Structure of The Tandem Bromodomain (bd1, Bd2) of Human Taf1 Bound to Mtorc1/2 Inhibitor Azd3147
  451. 7k0u: Crystal Structure of The Second Bromodomain (bd2) of Human Taf1 Bound to Plk1 Kinase Inhibitor Bi2536
  452. 7k1p: Crystal Structure of The Second Bromodomain (bd2) of Human Taf1 Bound to Bromosporine
  453. 7k27: Crystal Structure of The Tandem Bromodomain (bd1, Bd2) of Human Taf1 Bound to Atr Inhibitor Az20
  454. 7k3o: Crystal Structure of The Unliganded Second Bromodomain (bd2) of Human Taf1
  455. 7k42: Crystal Structure of The Second Bromodomain (bd2) of Human Taf1 Bound to Dioxane
  456. 7k6f: Crystal Structure of The Tandem Bromodomain (bd1, Bd2) of Human Taf1 in Complex with Mes (2-(n-morpholino)ethanesulfonic Acid)
  457. 7p4s: Bromodomain of Human Taf1 (2) with Naphthyridinone Compound
© Copyright 2008-2009 by enzymes.me.uk